DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

China flag China · Delayed Price · Currency is CNY
19.35
+0.60 (3.20%)
Apr 29, 2026, 3:00 PM CST
8.95%
Market Cap 21.35B
Revenue (ttm) 27.52B
Net Income (ttm) 1.29B
Shares Out 1.14B
EPS (ttm) 1.13
PE Ratio 16.62
Forward PE 15.62
Dividend 0.68 (3.63%)
Ex-Dividend Date Nov 6, 2025
Volume 9,934,971
Average Volume 5,815,058
Open 18.89
Previous Close 18.75
Day's Range 18.78 - 19.44
52-Week Range 15.50 - 21.78
Beta 0.64
RSI 68.54
Earnings Date Apr 24, 2026

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Sector Healthcare
Founded 1999
Employees 43,532
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2025, SHA:603233's revenue was 27.50 billion, an increase of 3.80% compared to the previous year's 26.50 billion. Earnings were 1.24 billion, an increase of 35.04%.

Financial Statements

News

There is no news available yet.